Endovenous laser ablation of great saphenous vein with ultrasound-guided perivenous tumescence： early and midterm results

作     者：CHEN Jia-quan XIE Hui DENG Hao-yu YUAN Kai ZHANG Ji-wei ZHANG Hao ZHANG Lan 

作者机构：Department of Vascular Surgery Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200127 China 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2013年第126卷第3期

页      面：421-425页

核心收录：

学科分类：090603[农学-临床兽医学] 0711[理学-系统科学] 07[理学] 08[工学] 080401[工学-精密仪器及机械] 09[农学] 0906[农学-兽医学] 0804[工学-仪器科学与技术] 080402[工学-测试计量技术及仪器] 

基　　金：The work was supported by a grant from the Shanghai Committee of Science and Technology China (No.10ZR1418800) 

主　　题：endovenous laser ablation great saphenous vein occlusion tumescent anaesthesia 

摘      要：Background Endovenous laser ablation （EVLA） is an improved method to treat varicose great saphenous veins （GSV） with a high satisfactory rate. This study aimed to evaluate the efficiency and safety of treatment by EVLA procedures with ultrasound-guided perivenous tumescence. Methods Thirty-one patients （31 limbs） with symptomatic varicose vein primary to chronic venous insufficiency （CVI） treated with EVLA were prospectively studied. The entire procedure was performed under ultrasound-guided tumescent local anesthesia. The patients were evaluated with a 18 month follow-up postoperation using clinical examination and venous duplex ultrasonography. Pain scores and quality of life （QOL） were recorded using visual analog scale （VAS） and the chronic venous insufficiency questionnaire （CIVIQ） at 1 week, 1 month, and 12 months after operation. Results All patients tolerated EVLA procedure well. The overall success occlusion rates of GSV were 92%, 94%, and 94% at 1, 12, and 18 months follow-up, respectively. The score of CIVIQ one week preoperation was 69.14±11.44 while that of CIVIQ one month postoperation was 85.32±4.89. The life quality has significantly improved after the operation of EVLA （t=12.71, P 〈0.05）. The VAS one month after treatment was lower than 1 week before therapy （t=8.048, P 〈0.05）. Major complications such as deep vein thrombosis and skin burns were not found. Most of the complications were minor and improved quickly. Conclusions This refinement type of EVLA procedure is a safe and effective treatment with a high satisfaction rate; it displayed noteworthy features including shortening hospitalization, early ambulant activity, and preferable occlusion rates.